Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
出版年份 2019 全文链接
标题
Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
作者
关键词
-
出版物
Frontiers in Endocrinology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-02-15
DOI
10.3389/fendo.2019.00080
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA
- (2019) Darren K. McGuire et al. CIRCULATION
- CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2018 EXECUTIVE SUMMARY
- (2018) Alan J. Garber et al. Endocrine Practice
- The safety of gliptins : updated data in 2018
- (2018) André Jacques Scheen Expert Opinion On Drug Safety
- DPP-4 is expressed in human pancreatic beta cells and its direct inhibition improves beta cell function and survival in type 2 diabetes
- (2018) Marco Bugliani et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes
- (2018) Carolyn F. Deacon PEPTIDES
- Oxyntomodulin: Actions and role in diabetes
- (2018) Jens J. Holst et al. PEPTIDES
- Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance
- (2018) Devram S. Ghorpade et al. NATURE
- Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition
- (2018) Elodie M. Varin et al. Cell Metabolism
- Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETOLOGIA
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
- (2018) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Insulin Secretion Depends on Intra-islet Glucagon Signaling
- (2018) Berit Svendsen et al. Cell Reports
- Saxagliptin but Not Sitagliptin Inhibits CaMKII and PKC via DPP9 Inhibition in Cardiomyocytes
- (2018) Chintan N. Koyani et al. Frontiers in Physiology
- Metabolic regulation of GLP-1 and PC1/3 in pancreatic α-cell line
- (2017) Veronica Sancho et al. PLoS One
- Pancreatic α Cell-Derived Glucagon-Related Peptides Are Required for β Cell Adaptation and Glucose Homeostasis
- (2017) Shuyang Traub et al. Cell Reports
- Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
- (2017) Christian Baumeier et al. Molecular Metabolism
- Differential Effects of Linagliptin on the Function of Human Islets Isolated from Non-diabetic and Diabetic Donors
- (2017) Yanqing Zhang et al. Scientific Reports
- Reduced DPP4 activity improves insulin signaling in primary human adipocytes
- (2016) Diana Röhrborn et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes
- (2016) Åsa Segerstolpe et al. Cell Metabolism
- HepaticDPP4DNA Methylation Associates With Fatty Liver
- (2016) Christian Baumeier et al. DIABETES
- Quantification of the Contribution of GLP-1 to Mediating Insulinotropic Effects of DPP-4 Inhibition With Vildagliptin in Healthy Subjects and Patients With Type 2 Diabetes Using Exendin [9-39] as a GLP-1 Receptor Antagonist
- (2016) Michael A. Nauck et al. DIABETES
- Pancreatic Safety of Sitagliptin in the TECOS Study
- (2016) John B. Buse et al. DIABETES CARE
- Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas
- (2016) C. F. Deacon et al. DIABETES OBESITY & METABOLISM
- Drug development from the bench to the pharmacy: with special reference to dipeptidyl peptidase-4 inhibitor development
- (2016) R. D. Carr DIABETIC MEDICINE
- Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus
- (2016) Darren K. McGuire et al. JAMA Cardiology
- Localization of dipeptidyl peptidase-4 (CD26) to human pancreatic ducts and islet alpha cells
- (2015) Petra Augstein et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
- (2015) Faiez Zannad et al. LANCET
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of high glucose on caveolin-1 and insulin signaling in 3T3-L1 adipocytes
- (2015) Sara Palacios-Ortega et al. Adipocyte
- Dipeptidyl peptidase-4 (DPP-4): Localization and activity in human and rodent islets
- (2014) Liehua Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Safety and Tolerability of Linagliptin in Patients With Type 2 Diabetes: A Comprehensive Pooled Analysis of 22 Placebo-controlled Studies
- (2014) Michael Lehrke et al. CLINICAL THERAPEUTICS
- Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin
- (2014) Itamar Raz et al. DIABETES CARE
- Restoration of the insulinotropic effect of glucose-dependent insulinotropic polypeptide contributes to the antidiabetic effect of dipeptidyl peptidase-4 inhibitors
- (2014) K. Aaboe et al. DIABETES OBESITY & METABOLISM
- Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes
- (2014) Bilal A. Omar et al. DIABETOLOGIA
- Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
- (2014) Erin E. Mulvihill et al. ENDOCRINE REVIEWS
- Quantification of Intact and Truncated Stromal Cell-Derived Factor-1α in Circulation by Immunoaffinity Enrichment and Tandem Mass Spectrometry
- (2014) Weixun Wang et al. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
- Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment
- (2014) Amy G. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic and anorexigenic activity
- (2013) Elisabetta Bianchi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade
- (2013) B. A. Aulinger et al. DIABETES
- Adipose Dipeptidyl Peptidase-4 and Obesity: Correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro
- (2013) H. Sell et al. DIABETES CARE
- The dipeptidylpeptidase-IV inhibitors sitagliptin, vildagliptin and saxagliptin do not impair innate and adaptive immune responses
- (2013) D. Anz et al. DIABETES OBESITY & METABOLISM
- Safety of saxagliptin: events of special interest in 9156 patients with type 2 diabetes mellitus
- (2013) Boaz Hirshberg et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- The DPP-4 Inhibitor Linagliptin Restores β-Cell Function and Survival in Human Isolated Islets Through GLP-1 Stabilization
- (2013) Payal Shah et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies
- (2013) Samuel S. Engel et al. Diabetes Therapy
- A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets
- (2012) P. Marchetti et al. DIABETOLOGIA
- Plasma dipeptidyl peptidase 4 activity correlates with body mass index and the plasma adiponectin concentration in healthy young people
- (2012) Yasushi Kirino et al. ENDOCRINE JOURNAL
- Impaired Incretin-Induced Amplification of Insulin Secretion after Glucose Homeostatic Dysregulation in Healthy Subjects
- (2012) Katrine B. Hansen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
- (2011) D. Lamers et al. DIABETES
- The increased dipeptidyl peptidase-4 activity is not counteracted by optimized glucose control in type 2 diabetes, but is lower in metformin-treated patients
- (2011) G. P. Fadini et al. DIABETES OBESITY & METABOLISM
- Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus—an adaptive response to hyperglycaemia?
- (2011) A. M. K. Hansen et al. DIABETOLOGIA
- Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival
- (2011) Z. Liu et al. DIABETOLOGIA
- Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?
- (2011) N M Whalley et al. JOURNAL OF ENDOCRINOLOGY
- Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism
- (2011) Masayuki Miyazaki Molecular Medicine Reports
- Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
- (2011) Helga Ellingsgaard et al. NATURE MEDICINE
- Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells
- (2010) Laura Pala et al. ACTA DIABETOLOGICA
- The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes: Possible role of stromal-derived factor-1
- (2010) G. P. Fadini et al. DIABETES CARE
- Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions
- (2010) L. Pala et al. DIABETIC MEDICINE
- The dipeptidyl peptidase IV family in cancer and cell biology
- (2010) Denise M. T. Yu et al. FEBS Journal
- Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents
- (2010) Y-L Liu et al. INTERNATIONAL JOURNAL OF OBESITY
- Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker
- (2010) Gábor Firneisz et al. PLoS One
- Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses
- (2009) Kalpit A Vora et al. BMC IMMUNOLOGY
- Synergy between CD26/DPP-IV Inhibition and G-CSF Improves Cardiac Function after Acute Myocardial Infarction
- (2009) Marc-Michael Zaruba et al. Cell Stem Cell
- Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus
- (2009) K. Aaboe et al. DIABETES OBESITY & METABOLISM
- Stromal cell-derived factor-1 promotes survival of pancreatic beta cells by the stabilisation of beta-catenin and activation of transcription factor 7-like 2 (TCF7L2)
- (2009) Z. Liu et al. DIABETOLOGIA
- Alogliptin Use in Elderly People: A Pooled Analysis from Phase 2 and 3 Studies
- (2009) Richard E. Pratley et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes
- (2008) P. V. Højberg et al. DIABETOLOGIA
- Investigation of Structure-Activity Relationships of Oxyntomodulin (Oxm) Using Oxm Analogs
- (2008) Maralyn R. Druce et al. ENDOCRINOLOGY
- Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function
- (2008) Kei Ohnuma et al. TRENDS IN IMMUNOLOGY
- Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects
- (2007) Aine M. McKillop et al. DIABETES RESEARCH AND CLINICAL PRACTICE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now